Acupuncture Provides Significant Pain Relief and Functional Improvement in Migraine Without Aura: JAMA

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2026-02-02 15:45 GMT   |   Update On 2026-02-02 15:45 GMT
Advertisement

China: A new trial has revealed that acupuncture effectively reduced pain and improved functional outcomes in patients with migraine without aura. Connectome-based predictive modeling identified specific brain connectivity patterns—default mode network and subcortical–cerebellar hypoconnectivity predicting pain relief, and subcortical–cerebellar–motor hyperconnectivity predicting reduced disability—supporting a personalized, brain-based treatment approach.

Advertisement
These findings were reported in a randomized clinical trial published in JAMA Network Open by Xinyu Zhang from the Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China, and colleagues. The study is among the first to integrate machine learning–based connectome analysis with clinical evaluation of acupuncture in migraine without aura (MWOA).
Migraine without aura is a common neurological disorder that significantly affects quality of life. Although acupuncture is widely used for migraine management, its mechanisms and predictors of response remain unclear. This study assessed the effectiveness of acupuncture versus sham treatment and examined whether baseline brain connectivity could predict treatment response.
The single-blinded randomized trial, conducted in Beijing between June 2021 and June 2023, included 120 adults aged 18 to 65 years with migraine without aura. Participants were randomly assigned to real or sham acupuncture and underwent baseline clinical assessments and resting-state fMRI.
Both groups received 12 sessions over four weeks. Real acupuncture used traditional acupoints with deqi sensation, while sham acupuncture used nonacupoints without deqi. The primary outcome was change in monthly migraine days, with secondary measures including headache frequency, medication use, pain severity, disability, and migraine-related quality of life.
The trial revealed the following findings:
  • Real acupuncture led to a significantly greater reduction in monthly migraine days compared with sham acupuncture.
  • Participants receiving real acupuncture experienced a meaningful decrease in overall headache frequency.
  • Use of acute migraine medications was reduced among patients treated with real acupuncture.
  • Pain intensity scores measured using the visual analog scale were significantly lower in the real acupuncture group.
  • Headache-related disability, assessed using the Headache Impact Test-6, showed notable improvement with real acupuncture.
  • Quality-of-life scores improved across multiple domains among participants receiving real acupuncture.
  • Connectome-based predictive modeling using baseline fMRI data demonstrated that whole-brain functional connectivity patterns could predict individual responses to acupuncture.
  • Reduced connectivity between the default mode network and subcortical–cerebellar regions was associated with greater pain relief.
  • Increased connectivity between subcortical–cerebellar and motor networks predicted greater reductions in migraine-related disability.
The authors noted several limitations, including the exclusion of other migraine subtypes, which may limit generalizability, and the absence of posttreatment MRI scans to capture dynamic brain changes over time. Nevertheless, the findings provide compelling evidence that acupuncture is effective for MWOA and that brain connectivity signatures may serve as objective biomarkers to guide personalized treatment strategies.
Overall, the study highlights the potential of combining neuroimaging and machine learning approaches with traditional therapies to optimize migraine management and tailor treatment to individual patients.
Reference:
Zhang X, Chen Q, Liu Y, et al. Acupuncture for Migraine Without Aura and Connection-Based Efficacy Prediction: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(1):e2555454. doi:10.1001/jamanetworkopen.2025.55454


Tags:    
Article Source : JAMA Network Open

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News